SC
CVS icon

Stephens Consulting’s CVS Health CVS Stock Holding History

Stephens Consulting’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.97K Hold
50
– – ﹤0.01% 306
2025
Q3 		$3.77K Sell
50
-39
-44% -$2.67K ﹤0.01% 290
2025
Q2 		$6.14K Sell
89
-66
-43% -$4.33K ﹤0.01% 376
2025
Q1 		$10.5K Hold
155
– – ﹤0.01% 319
2024
Q4 		$6.96K Sell
155
-164
-51% -$9.2K ﹤0.01% 386
2024
Q3 		$20K Sell
319
-295
-48% -$17.2K 0.01% 264
2024
Q2 		$36.3K Sell
614
-253
-29% -$15.8K 0.01% 210
2024
Q1 		$69.2K Sell
867
-201
-19% -$15.4K 0.02% 151
2023
Q4 		$84.4K Sell
1,068
-4
-0.4% -$285 0.03% 126
2023
Q3 		$74.8K Buy
1,072
+2
+0.2% +$142 0.03% 132
2023
Q2 		$74K Sell
1,070
-78
-7% -$5.55K 0.03% 129
2023
Q1 		$85.3K Sell
1,148
-200
-15% -$16.8K 0.05% 122
2022
Q4 		$126K Hold
1,348
– – 0.08% 90
2022
Q3 		$129K Buy
1,348
+2
+0.1% +$198 0.12% 86
2022
Q2 		$125K Buy
1,346
+2
+0.1% +$195 0.1% 86
2022
Q1 		$136K Sell
1,344
-12
-0.9% -$1.26K 0.11% 100
2021
Q4 		$140K Buy
+1,356
New +$125K 0.12% 124

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stephens Consulting's CVS Position: Q4 2025 in Review

Stephens Consulting held its CVS Health (CVS) position steady in Q4 2025 at 50 shares worth $3.97K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Stephens Consulting first reported a position in CVS in Q4 2021 and has held it in 17 quarters since. The position peaked at $140K in Q4 2021. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • Stephens Consulting held 50 shares of CVS Health worth $3.97K as of Q4 2025.
  • Stephens Consulting left its CVS Health share count unchanged in Q4 2025.
  • CVS Health made up ﹤0.01% of Stephens Consulting's portfolio in Q4 2025, its #306 holding.
  • Stephens Consulting first reported a position in CVS Health in Q4 2021 and has held it in 17 quarters since.
  • Stephens Consulting's CVS Health position peaked at $140K in Q4 2021.
  • 1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.